mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
7e-07 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
4e-06 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
4e-06 |